Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.

Eur Respir J · 2022 · PMC8832375 · PMID 35144989

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

However, the results suggest that the addition of inhaled budesonide to usual care in patients hospitalised because of COVID-19 pneumonia is safe and showed an encouraging trend towards a reduction in disease progression.

also in 355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.